Letters

Spironolactone and risk of upper gastrointestinal events: Author's reply

BMJ 2006; 333 doi: https://doi.org/10.1136/bmj.333.7566.500-d (Published 31 August 2006) Cite this as: BMJ 2006;333:500
  1. Katia M Verhamme, senior researcher (k.verhamme@erasmusmc.nl),
  2. Jeanne P Dieleman, senior researcher,
  3. Bruno H Ch Stricker, professor of pharmacoepidemiology,
  4. Miriam C J M Sturkenboom, associate professor
  1. Department of Medical Informatics, Erasmus MC, 3000 DR Rotterdam, Netherlands,

    EDITOR—With interest, we have read the rapid responses to our article and would like to reply to some of the questions and concerns that have been raised.

    Campbell et al questioned …

    View Full Text

    Sign in

    Log in through your institution

    Free trial

    Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
    Sign up for a free trial

    Subscribe